Global Uterine Cancer Therapeutics & Diagnostics Market by Cancer Type (Adenosquamous Carcinoma, Endometrial Adenocarcinoma, Papillary Serous Carcinoma), Product (Diagnostics, Therapeutics) - Forecast 2024-2030- Product Image

Sale

Global Uterine Cancer Therapeutics & Diagnostics Market by Cancer Type (Adenosquamous Carcinoma, Endometrial Adenocarcinoma, Papillary Serous Carcinoma), Product (Diagnostics, Therapeutics) - Forecast 2024-2030

Report
184 Pages
March 2024
Region: Global
360iResearch™
ID: 4896801

UP TO €845EUR$875USD£723GBP OFF until Dec 31^st 2024

The Uterine Cancer Therapeutics & Diagnostics Market size was estimated at USD 22.55 billion in 2023, USD 23.95 billion in 2024, and is expected to grow at a CAGR of 6.29% to reach USD 34.59 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Uterine Cancer Therapeutics & Diagnostics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Uterine Cancer Therapeutics & Diagnostics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Uterine Cancer Therapeutics & Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AbbVie Inc., Ability Pharma, AstraZeneca PLC, BioMerieux S.A., Danaher Corporation, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Johnson & Johnson Services, Inc., Merck & Co., Inc., Pfizer Inc., Sanofi S.A., Siemens Healthineers AG, and Takeda Pharmaceutical Co. Ltd.

Market Segmentation & Coverage

This research report categorizes the Uterine Cancer Therapeutics & Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

Cancer Type
- Adenosquamous Carcinoma
- Endometrial Adenocarcinoma
- Papillary Serous Carcinoma
- Uterine Sarcoma
Product
- Diagnostics
  - Biopsy
  - CT Scan
  - Dilation & Curettage
  - Hysteroscopy
  - Pelvic Ultrasound
- Therapeutics
  - Chemotherapy
  - Immunotherapy
  - Radiation Therapy
  - Surgery

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Uterine Cancer Therapeutics & Diagnostics Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Uterine Cancer Therapeutics & Diagnostics Market?
What are the technology trends and regulatory frameworks in the Uterine Cancer Therapeutics & Diagnostics Market?
What is the market share of the leading vendors in the Uterine Cancer Therapeutics & Diagnostics Market?
Which modes and strategic moves are suitable for entering the Uterine Cancer Therapeutics & Diagnostics Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Uterine Cancer Therapeutics & Diagnostics Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing awareness of uterine cancer in physicians and healthcare providers
5.1.1.2. Rising in importance of the women health
5.1.1.3. Increasing healthcare expenditure and rising focus of government on providing adequate healthcare solutions
5.1.2. Restraints
5.1.2.1. Expensive treatment methods along with adverse side effects and severe toxicity of the medications
5.1.3. Opportunities
5.1.3.1. Increasing advancements in the cancer screening and treatment methods
5.1.3.2. Developing countries organising various programmes about uterine cancer severity and importance
5.1.4. Challenges
5.1.4.1. Low success rate of cancer drug clinical trials
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization

6. Uterine Cancer Therapeutics & Diagnostics Market, by Cancer Type

6.1. Introduction
6.2. Adenosquamous Carcinoma
6.3. Endometrial Adenocarcinoma
6.4. Papillary Serous Carcinoma
6.5. Uterine Sarcoma

7. Uterine Cancer Therapeutics & Diagnostics Market, by Product

7.1. Introduction
7.2. Diagnostics
7.3.1. Biopsy
7.3.2. CT Scan
7.3.3. Dilation & Curettage
7.3.4. Hysteroscopy
7.3.5. Pelvic Ultrasound
7.3. Therapeutics
7.4.1. Chemotherapy
7.4.2. Immunotherapy
7.4.3. Radiation Therapy
7.4.4. Surgery

8. Americas Uterine Cancer Therapeutics & Diagnostics Market

8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Uterine Cancer Therapeutics & Diagnostics Market

9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Uterine Cancer Therapeutics & Diagnostics Market

10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape

11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

12.1. Key Company Profiles
12.1.1. Abbott Laboratories
12.1.2. AbbVie Inc.
12.1.3. Ability Pharma
12.1.4. AstraZeneca PLC
12.1.5. BioMerieux S.A.
12.1.6. Danaher Corporation
12.1.7. Eli Lilly and Company
12.1.8. F. Hoffmann-La Roche AG
12.1.9. GlaxoSmithKline PLC
12.1.10. Johnson & Johnson Services, Inc.
12.1.11. Merck & Co., Inc.
12.1.12. Pfizer Inc.
12.1.13. Sanofi S.A.
12.1.14. Siemens Healthineers AG
12.1.15. Takeda Pharmaceutical Co. Ltd.
12.2. Key Product Portfolio

13. Appendix

13.1. Discussion Guide
13.2. License & Pricing

List of Figures

FIGURE 1. UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, 2022 VS 2030
FIGURE 3. UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET DYNAMICS
FIGURE 7. UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2022 VS 2030 (%)
FIGURE 8. UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 10. UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 12. AMERICAS UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 14. UNITED STATES UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 20. UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2022

List of Tables

TABLE 1. UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 6. UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY ADENOSQUAMOUS CARCINOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY ENDOMETRIAL ADENOCARCINOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PAPILLARY SEROUS CARCINOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY UTERINE SARCOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 11. UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 13. UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CT SCAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY DILATION & CURETTAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY HYSTEROSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PELVIC ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 20. UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 37. CANADA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 38. CANADA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 39. CANADA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 40. CANADA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 41. MEXICO UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 42. MEXICO UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 43. MEXICO UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 44. MEXICO UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 55. AUSTRALIA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 56. AUSTRALIA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. AUSTRALIA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 58. AUSTRALIA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 59. CHINA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 60. CHINA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 61. CHINA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 62. CHINA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 63. INDIA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 64. INDIA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 65. INDIA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 66. INDIA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 67. INDONESIA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 68. INDONESIA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. INDONESIA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 70. INDONESIA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 71. JAPAN UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 72. JAPAN UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 73. JAPAN UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 74. JAPAN UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 75. MALAYSIA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 76. MALAYSIA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 77. MALAYSIA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 78. MALAYSIA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 79. PHILIPPINES UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 80. PHILIPPINES UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 81. PHILIPPINES UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 82. PHILIPPINES UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 83. SINGAPORE UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 84. SINGAPORE UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 85. SINGAPORE UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 86. SINGAPORE UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 87. SOUTH KOREA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 88. SOUTH KOREA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. SOUTH KOREA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 90. SOUTH KOREA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 91. TAIWAN UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 92. TAIWAN UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 94. TAIWAN UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 95. THAILAND UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 96. THAILAND UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. THAILAND UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 98. THAILAND UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 99. VIETNAM UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 100. VIETNAM UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 102. VIETNAM UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 108. DENMARK UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 109. DENMARK UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 110. DENMARK UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 111. DENMARK UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 112. EGYPT UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 113. EGYPT UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 114. EGYPT UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 115. EGYPT UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 116. FINLAND UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 117. FINLAND UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 118. FINLAND UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 119. FINLAND UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 120. FRANCE UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 121. FRANCE UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 122. FRANCE UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 123. FRANCE UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 124. GERMANY UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 125. GERMANY UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 126. GERMANY UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 127. GERMANY UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 128. ISRAEL UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 129. ISRAEL UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 131. ISRAEL UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 132. ITALY UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 133. ITALY UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 134. ITALY UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 135. ITALY UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 140. NIGERIA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 141. NIGERIA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 142. NIGERIA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 143. NIGERIA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 144. NORWAY UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 145. NORWAY UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 146. NORWAY UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 147. NORWAY UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 148. POLAND UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 149. POLAND UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 150. POLAND UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 151. POLAND UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 152. QATAR UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 153. QATAR UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 154. QATAR UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 155. QATAR UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 168. SPAIN UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 169. SPAIN UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 170. SPAIN UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 171. SPAIN UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 172. SWEDEN UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 173. SWEDEN UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 176. SWITZERLAND UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 177. SWITZERLAND UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 178. SWITZERLAND UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 179. SWITZERLAND UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 180. TURKEY UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 181. TURKEY UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 182. TURKEY UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 183. TURKEY UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 192. UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 193. UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 194. UTERINE CANCER THERAPEUTICS & DIAGNOSTICS MARKET LICENSE & PRICING

Companies Mentioned

Abbott Laboratories
AbbVie Inc.
Ability Pharma
AstraZeneca PLC
BioMerieux S.A.
Danaher Corporation
Eli Lilly and Company
F. Hoffmann-La Roche AG
GlaxoSmithKline PLC
Johnson & Johnson Services, Inc.
Merck & Co., Inc.
Pfizer Inc.
Sanofi S.A.
Siemens Healthineers AG
Takeda Pharmaceutical Co. Ltd.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	184
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 23.95 Billion
Forecasted Market Value ( USD ) by 2030	$ 34.59 Billion
Compound Annual Growth Rate	6.2%
Regions Covered	Global
No. of Companies Mentioned	15

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3259EUR$3,374USD£2,787GBP €3621EUR$3,749USD£3,097GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4129EUR$4,274USD£3,530GBP €4587EUR$4,749USD£3,923GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€4998EUR$5,174USD£4,274GBP €5553EUR$5,749USD£4,749GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5867EUR$6,074USD£5,017GBP €6519EUR$6,749USD£5,575GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7606EUR$7,874USD£6,504GBP €8451EUR$8,749USD£7,227GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Uterine Cancer Therapeutics and Diagnostics: Global Strategic Business Report

Uterine Cancer Therapeutics & Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

Uterine Cancer Diagnostics Market Report: Trends, Forecast and Competitive Analysis to 2030

Uterine Cancer Diagnostic Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)